Gut mucosal granulocyte activation precedes nitric oxide production: Studies in coeliac patients challenged with gluten and corn

Gut

Volumn 54, Issue 6, 2005, Pages 769-774

  Kristjansson G ^a   Hogman M ^a   Venge, P ^a   Hallgren R ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; GLUTEN; HISTAMINE; MYELOPEROXIDASE; NITRIC OXIDE;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORN; CORRELATION ANALYSIS; FEMALE; GAS ANALYSIS; GRANULOCYTE; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE MUCOSA; LEUKOCYTE ACTIVATION; MAIZE; MALE; MEASUREMENT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RECTUM; RECTUM MUCOSA; WHEAT;

ADMINISTRATION, RECTAL; ADULT; AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CELIAC DISEASE; EOSINOPHIL CATIONIC PROTEIN; EOSINOPHILS; FEMALE; GLUTEN; HISTAMINE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEUTROPHILS; NITRIC OXIDE; PEROXIDASE; RECTUM; ZEA MAYS;

EID: 19544373309     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.057174     Document Type: Article

References (41)

1. Pfeiffer CJ, Qiu BS. Effects of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J Pharm Pharmacol 1995;47:827-32.
2. Rachmilewitz D, Karmeli F, Okon E, et al. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995;37:247-55.
3. McCafferty DM, Mudgett JS, Swain MG, et al. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997;112:1022-7.
4. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
5. Moncada S, Higgs A, Furchgott R. International Union of Pharmacology Nomenclature in Nitric Oxide Research. Pharmacol Rev 1997;49:137-42.
6. Everts B, Stotzer P, Olsson M, et al. Increased luminal nitric oxide concentrations in the small intestine of patients with coeliac disease. Eur J Clin Invest 1999:29:692-6.
7. Loft DE, Marsh MN, Sandle GI, et al. Studies of intestinal lymphoid tissue. XII. Epithelial lymphocyte and mucosal responses to rectal gluten challenge in celiac sprue. Gastroenterology 1989;97:29-37.
8. Torre P, Fusco S, Quaglia F, et al. Immune response of the coeliac nasal mucosa to locally-instilled gliadin. Clin Exp Immunol 2002;127:513-18.
9. Lahteenoja H, Maki M, Viander M, et al. Local challenge of oral mucosa with gliadin in patients with coeliac disease. Clin Exp Immunol 2000;120:38-45.
10. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000;119:234-42.
11. Maiuri L, Ciacci C, Ricciardelli I, et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003;362:30-7.
12. Kristjansson G, Venge P, Wanders A, et al. Clinical and subclinical intestinal inflammation assessed by the mucosal patch technique: studies of mucosal neutrophil and eosinophil activation in inflammatory bowel diseases and irritable bowel syndrome. Gut 2004;53:1806-12.
13. Herulf M, Ljung T, Hellström PM, et al. Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method. Scand J Gastroenterol 1998;33:164-9.
14. Miller MJ, Zhang XJ, Sadowska-Krowicka H, et al. Nitric oxide release in response to gut injury. Scand J Gastroenterol 1993;28:149-54.
15. Thomassen MJ, Kavuru MS. Human alveolar macrophages and monocytes as a source and target for nitric oxide. Int Immunopharmacol 2001;1:1479-90.
16. Iijima H, Duguet A, Eum SY, et al. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med 2001;163:1233-40.
17. Forsythe P, Gilchrist M, Kulka M, et al. Mast cells and nitric oxide: control of production, mechanisms of response. Int Immunopharmacol 2001;1:1525-41.
18. Armstrong R. The physiological role and pharmacological potential of nitric oxide in neutrophil activation. Int Immunopharmacol 2001;1:1501-12.
19. Kamimura Y, Fujii T, Kojima H, et al. Nitric oxide (NO) synthase mRNA expression and NO production via muscarinic acetylcholine receptor-mediated pathways in the CEM, human leukemic T-cell line. Life Sci 2003;72:2151-4.
20. Niveloni S, Weksler-Zangen S, Pedreira S, et al. Time course of nitric oxide synthase generation after gluten exposure in the rectal mucosa of gluten-sensitive patients. Scand J Gastroenterol 2000;35:1150-6.
21. Grisham MB, Pavlick KP, Laroux FS, et al. Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease. J Investig Med 2002;50:272-83.
22. Herulf M, Blomquist L, Ljung T, et al. Increased rectal nitric oxide in coeliac disease after local challenge with gluten. Scand J Gastroenterol 2001;36:169-73.
23. Forstermann U, Pollock JS, Tracey WR, et al. Isoforms of nitric-oxide synthase: purification and regulation. Methods Enzymol 1994;233:258-64.
24. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915-18.
25. Fischer A, Folkerts G, Geppetti P, et al. Mediators of asthma: nitric oxide. Pulm Pharmacol Ther 2002;15:73-81.
26. Barnes PJ, Belvisi MG. Nitric oxide and lung disease. Thorax 1993;48:1034-43.
27. Payne DN, Adcock IM, Wilson NM, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone. Am J Respir Crit Care Med 2001;164:1376-81.
28. Ensari A, Ager A, Marsh MN, et al. Time-course of adhesion molecule expression in rectal mucosa of gluten-sensitive subjects after gluten challenge. Clin Exp Immunol 1993;92:303-7.
29. Kumar PJ, O'Donoghue DP, Stenson K, et al. Reintroduction of gluten in adults and children with treated coeliac disease. Gut 1979;20:743-9.
30. Horvath I, Donnelly LE, Kiss A, et al. Combined use of exhaled hydrogen peroxide and nitric oxide in monitoring asthma. Am J Respir Crit Care Med 1998;158:1042-6.
31. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91-5.
32. del Pozo V, de Arruda-Chaves E, de Andres B, et al. Eosinophils transcribe and translate messenger RNA for inducible nitric oxide synthase. J Immunol 1997;158:859-64.
33. Lim S, Jatakanon A, Meah S, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000;55:184-8.
34. Jatakanon A, Uasuf C, Maziak W, et al. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999;160:1532-9.
35. Clancy RM, Amin AR, Abramson SB. The role of nitric oxide in inflammation and immunity. Arthritis Rheum 1998;41:1141-51.
36. Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J 1997;11:118-24.
37. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-13.
38. Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996;111:871-85.
39. Troncone R, Auricchio S, De Vincenzi M, et al. An analysis of cereals that react with serum antibodies in patients with coeliac disease. J Pediatr Gastroenterol Nutr 1987;6:346-50.
40. Faulkner-Hogg KB, Selby WS, Loblay RH. Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: the role of trace amounts of gluten and non-gluten food intolerances. Scand J Gastroenterol 1999;34:784-9.
41. Collin P, Thorell L, Kaukinen K, et al. The safe threshold for gluten contamination in gluten-free products. Can trace amounts be accepted in the treatment of coeliac disease? Aliment Pharmacol Ther 2004;19:1277-83.